Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis. https://t.co/HX6tIsSz3I
Interesting use of IBM’s Watson for research... https://t.co/2aTRlDey5Z
@PaulLikeMe Work done with the Barrow Institute - see this : https://t.co/mTyOTDHX3w
Clinical utility of @IBMWatsonHealth for ALS https://t.co/tElC4dMPh0 and cancer http:// https://t.co/EgI9FqC29Y @IBMWatsonHealth "Initially, new technologies have minimal value, but in time, products improve and value increases exponentially." Disrupt o
@BarrowNeuro Full manuscript here: https://t.co/jAurwhIg9G
#Artificialintelligence in #neurodegenerativedisease research: use of #IBMWatson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis ♻️📑💻 https://t.co/fCrFXvU9s5
RT @ActaNeuropathol: Artificial intelligence à la IBM Watson reveals new proteins involved in #amyotrophic lateral sclerosis. https://t.co/…
RT @ActaNeuropathol: Artificial intelligence à la IBM Watson reveals new proteins involved in #amyotrophic lateral sclerosis. https://t.co/…
RT @ActaNeuropathol: Artificial intelligence à la IBM Watson reveals new proteins involved in #amyotrophic lateral sclerosis. https://t.co/…
RT @ActaNeuropathol: Artificial intelligence à la IBM Watson reveals new proteins involved in #amyotrophic lateral sclerosis. https://t.co/…
5 RBPs previously unlinked to ALS, hnRNPU, Syncrip, RBMS3, Caprin-1 and NUPL2, showed significant alterations in ALS compared to controls. https://t.co/b2agNavvlM
Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis. https://t.co/FCrg6LH0R1 https://t.co/EIGcScoTht
Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-bindin… https://t.co/aligFmpi7w